SL
Sudan Loganathan Stephens & Co Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
19
Avg Return
Past Year
Past Year
9.6%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
90.5%
Neutral
9.5%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Medical Devices
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $30 |
41%
upside
| 3 | +42% |
0
%
| 4 Mar ‘26 5 days ago |
|
|
|
Overweight
Maintained
| $100 |
18%
upside
| 2 | -2.6% |
0
%
| 2 Mar ‘26 7 days ago |
|
|
|
Overweight
Initiated
| $95 |
27%
upside
| 1 | +0.21% |
0
%
| 17 Dec ‘25 2 months ago |
|
|
|
Overweight
Reiterated
| $15 |
192%
upside
| 2 | -2.5% |
0
%
| 8 Dec ‘25 3 months ago |
|
|
|
Overweight
Maintained
| $8 |
433%
upside
| 1 | -69% |
0
%
| 24 Nov ‘25 3 months ago |
|
|
|
Overweight
Maintained
| $15 |
12%
upside
| 2 | +33% |
0
%
| 10 Nov ‘25 3 months ago |
|
|
|
Overweight
Maintained
| $18 |
97%
upside
| 2 | -17% |
0
%
| 5 Nov ‘25 4 months ago |
|
|
|
Overweight
Initiated
| $35 |
34%
upside
| 1 | +6.7% |
0
%
| 28 Oct ‘25 4 months ago |
|
|
|
Overweight
Reiterated
| $6 |
67%
upside
| 2 | +16% |
0
%
| 22 Sep ‘25 5 months ago |
|
|
|
Overweight
Reiterated
| $45 |
28%
upside
| 1 | +50% |
0
%
| 9 Sep ‘25 6 months ago |
|
|
|
Overweight
Reiterated
| $30 |
94%
upside
| 1 | +18% |
0
%
| 10 Jul ‘25 8 months ago |
|
|
|
Overweight
Upgraded
| $60 |
42%
upside
| 1 | -2.3% |
0
%
| 24 Jun ‘25 8 months ago |
|
|
|
Equal-Weight
Downgraded
| $135 |
4%
upside
| 1 | +47% |
–
| 3 Jun ‘25 9 months ago |
|
|
|
Equal-Weight
Downgraded
| $1 |
174%
upside
| 1 | -41% |
–
| 24 Mar ‘25 11 months ago |
|